Vanda Pharmaceuticals Inc. (VNDA) Deep Dive Video

Vanda is a cash-rich small-cap biotech trying to outrun a 2027 patent cliff—now armed with a newly approved first-in-40-years motion-sickness drug and multiple near-term FDA catalysts.